Owners, management and financials
CVR: 44032589
DKK -2,381,639
Gross profit
Net result: DKK -4,638,321
Ulrik Bjerl Nielsen (33,33-49,99%), Seandean Lykke Harwood Holding ApS (25-33,32%)
2 more
CVR · view owners
Austin Wayne Boesch
Board: Ulrik Bjerl Nielsen (chair) and 2 members
CVR · view management
Active
Founded 24 April 2023
CVR · view overview
6 employees
CVR · 2026
Director role ended: Sean Dean Lykke Harwood
CVR · 01/08/2026
View the full event history
Troya Therapeutics ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2023. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Austin Wayne Boesch. The board consists of Ulrik Bjerl Nielsen (chair), Christian Grøndahl and Sean Dean Lykke Harwood. The company's owners include Ulrik Bjerl Nielsen, Seandean Lykke Harwood Holding ApS and EnghildThøgersen Holding ApS. The company has 6 employees (2026). In 2025, the company reported a gross profit of DKK -2,381,639 and a net result of DKK -4,638,321 compared with DKK -1,440,941 the year before. Equity in the 2025 report amounted to DKK -6,398,479.
Selskabets formål er forskning, udvikling og kommercialisering af lægemidler.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | -2.4M | -4.6M | 9.9M | -6.4M | 4 | |
| 202401/01/2024 – 31/12/2024 | -991K | -1.4M | 3.9M | -1.8M | 0 |
Compared to 1.036 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningThe CVR number of Troya Therapeutics ApS is 44032589.
The owners of Troya Therapeutics ApS include Ulrik Bjerl Nielsen, Seandean Lykke Harwood Holding ApS and EnghildThøgersen Holding ApS.
The management of Troya Therapeutics ApS consists of Austin Wayne Boesch.
The board of Troya Therapeutics ApS consists of Ulrik Bjerl Nielsen, Christian Grøndahl and Sean Dean Lykke Harwood, with Ulrik Bjerl Nielsen as chair.
In 2025, Troya Therapeutics ApS reported a gross profit of DKK -2,381,639.
Troya Therapeutics ApS had 6 employees in 2026 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
Contact info changed: new website: www.troya-tx.com (August 4, 2026).
As of August 1, 2026, Austin Wayne Boesch is registered as adm. dir. of Troya Therapeutics ApS.
As of August 1, 2026, Sean Dean Lykke Harwood has stepped down as director of Troya Therapeutics ApS.
Contact info changed: new website: www.troya-tx.com (May 19, 2026).
Troya Therapeutics ApS has published its annual report for 2025. Gross profit came to DKK -2,381,639, and the net result was DKK -4,638,321.
As of December 22, 2025, Christian Grøndahl has joined the board of directors of Troya Therapeutics ApS.
As of December 22, 2025, Jan Johannes Enghild has left the board of directors of Troya Therapeutics ApS.
Troya Therapeutics ApS has published its annual report for 2024. Gross profit came to DKK -991,416, and the net result was DKK -1,440,941.
As of March 7, 2025, Ulrik Bjerl Nielsen is registered as an owner of Troya Therapeutics ApS with an ownership share of 33%.
As of March 7, 2025, is registered as an owner of Troya Therapeutics ApS with an ownership share of 10%.
Troya Therapeutics ApS has published its interim report for the period April 24, 2023 to December 31, 2023.
As of April 24, 2023, Jan Johannes Enghild has joined the board of directors of Troya Therapeutics ApS.
As of April 24, 2023, Ulrik Bjerl Nielsen has joined the board of directors of Troya Therapeutics ApS.
As of April 24, 2023, Sean Dean Lykke Harwood has joined the board of directors of Troya Therapeutics ApS.
As of April 24, 2023, Sean Dean Lykke Harwood is registered as director of Troya Therapeutics ApS.
As of April 24, 2023, Seandean Lykke Harwood Holding ApS is registered as an owner of Troya Therapeutics ApS with an ownership share of 25%.
As of April 24, 2023, EnghildThøgersen Holding ApS is registered as an owner of Troya Therapeutics ApS with an ownership share of 20%.
Troya Therapeutics ApS was founded on April 24, 2023.
Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.
Selskabets formål er at udvikle, markedsføre, sælge og implementere software produkter til brug ved indkøbsstyring og dermed efter bestyrelsens skøn beslægtet virksomhed
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Companies in the same industry and area
CVR 36465972
CVR 45436497
CVR 46059220
CVR 41978074
CVR 46543912
